Cutting Edge: Natalizumab Blocks Adhesion but Not Initial Contact of Human T Cells to the Blood-Brain Barrier In Vivo in an Animal Model of Multiple Sclerosis
Year: 2009
Type: article
Source: The Journal of Immunology
Institutions: University of Bern, Elan Pharmaceuticals, Inc. (Ireland)
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funders: Biogen, IC Design Education Center
OpenAlex ID: W1500346549
